Idiopathic Thrombocytopenic Purpura (ITP)

What is ITP?

Immune thrombocytopenic purpura (ITP) is an autoimmune disease in which your body attacks its own platelets – small cells in your blood that that help to build a clot to stop bleeding.
People with ITP often experience purple bruises and red or purple skin discolorations, as well as nosebleeds, bleeding of the gums, heavy menstrual bleeding, and hematomas. CSL Behring offers immunoglobulin therapies to increase a patient’s platelet counts.

Resources for you

Product Websites (United States) (United Kingdom) (United States)

Treatments Available

Availability of treatments may vary from country to country. Please be sure to visit your local site for further information.

Privigen® Immune Globulin Intravenous (Human) 10% Liquid Visit Website pdf
Carimune® NF / Sandoglobulin® / Redimune® / Sanglopor® Immune Globulin Intravenous (Human) Visit Website pdf
Rhophylac® Rho(D) Immune Globulin Intravenous (Human)  Visit Website pdf
Group meeting

Participate in Clinical Trials

Discover what is involved in participating in one of our clinical trials and how you can enroll.

Learn More

Get our latest news in your inbox
First name
Last name


You have now been added
to the CSL Behring news list